Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28169942 | 0.81 | PDE3B (0.42) | PDE3BPDE3AAKR1C3AKR1C2TRPV1 | |
| SCHEMBL27664128 | 0.74 | AKR1C3 (0.39) | AKR1C3AKR1C2SLC6A4 | |
| SCHEMBL27782036 | 0.73 | AKR1C3 (0.45) | AKR1C3AKR1C2 | |
| SCHEMBL10265137 | 0.73 | AKR1C3 (0.38) | AKR1C3AKR1C2 | |
| SCHEMBL27689100 | 0.71 | PDE2A (0.41) | AKR1C3AKR1C2DAO | |
| SCHEMBL27664098 | 0.71 | KIF11 (0.46) | AKR1C3AKR1C2 | |
| SCHEMBL25530531 | 0.71 | PDE3B (0.45) | PDE3BPDE3ADAOTRPV1 | |
| SCHEMBL19789643 | 0.70 | PDE3B (0.47) | PDE3BPDE3ADAOSLC6A2SLC6A4 | |
| SCHEMBL17891892 | 0.70 | PDE3B (0.44) | PDE3BPDE3AAKR1C3AKR1C2 | |
| SCHEMBL17831713 | 0.70 | PDE3B (0.44) | PDE3BPDE3AAKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001286-A | The assimilation compound of dihydro-pyrimidin 2 and its medical usage | 日本烟草产业株式会社 | 2017-08-01 | — | — | CN | disclosed |